Gufic Bio invests ₹5.75 Cr in Saraswat Co-operative Bank

Gufic Biosciences Ltd's board approved a further investment of ₹5.75 Crores in Saraswat Co-operative Bank Limited by subscribing to 57,50,800 equity shares with a face value of ₹10 each. This investment aims to strengthen the existing banking relationship and credit exposure, aligning with the company's investment and treasury management strategy. The acquisition is not a related party transaction, and no promoter group has an interest in it. Post-acquisition, Gufic will hold 57,58,300 shares in Saraswat Bank.